|
Q1 FY2022
As of Dec 31, 2021
|
Q4 FY2021
As of Sep 30, 2021
|
Q3 FY2021
As of Jun 30, 2021
|
Q2 FY2021
As of Mar 31, 2021
|
Q1 FY2021
As of Dec 31, 2020
|
Q4 FY2020
As of Sep 30, 2020
|
Q3 FY2020
As of Jun 30, 2020
|
Q2 FY2020
As of Mar 31, 2020
|
Q1 FY2020
As of Dec 31, 2019
|
Q4 FY2019
As of Sep 30, 2019
|
Q3 FY2019
As of Jun 30, 2019
|
Q2 FY2019
As of Mar 31, 2019
|
Q1 FY2019
As of Dec 31, 2018
|
Q4 FY2018
As of Sep 30, 2018
|
Q3 FY2018
As of Jun 30, 2018
|
Q2 FY2018
As of Mar 31, 2018
|
Q1 FY2018
As of Dec 31, 2017
|
Q4 FY2017
As of Sep 30, 2017
|
Q3 FY2017
As of Jun 30, 2017
|
Q2 FY2017
As of Mar 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Real Estate Investments: | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Buildings and Improvements | ||||||||||||||||||||
| Total Real Estate Investments | ||||||||||||||||||||
| Accumulated Depreciation | ||||||||||||||||||||
| Real Estate Investments | ||||||||||||||||||||
| Cash and Cash Equivalents | ||||||||||||||||||||
| Securities Available for Sale at Fair Value | ||||||||||||||||||||
| Tenant and Other Receivables | ||||||||||||||||||||
| Straight-line Rent Receivable | ||||||||||||||||||||
| Deferred Rent Receivable | ||||||||||||||||||||
| Prepaid Expenses | ||||||||||||||||||||
| Intangible Assets, net of Accumulated Amortization of $20,272 and $19,669, respectively | ||||||||||||||||||||
| Capitalized Lease Costs, net of Accumulated Amortization of $4,633 and $4,435, respectively | ||||||||||||||||||||
| Financing Costs, net of Accumulated Amortization of $939 and $745, respectively | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Fixed Rate Mortgage Notes Payable, net of Unamortized Debt Issuance Costs | ||||||||||||||||||||
| Loans Payable | ||||||||||||||||||||
| Accounts Payable and Accrued Expenses | ||||||||||||||||||||
| Other Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders’ Equity: | ||||||||||||||||||||
| 6.125% Series C Cumulative Redeemable Preferred Stock, $0.01 Par Value Per Share: 26,600 Shares Authorized as of December 31, 2021 and September 30, 2021; 21,986 Shares Issued and Outstanding as of December 31, 2021 and September 30, 2021 | ||||||||||||||||||||
| Total 6.125% Series C Cumulative Redeemable Preferred Stock, $0.01 Par Value Per Share: 26,600 Shares Authorized as of December 31, 2021 and September 30, 2021; 21,986 Shares Issued and Outstanding as of December 31, 2021 and September 30, 2021 | ||||||||||||||||||||
| Common Stock, $0.01 Par Value Per Share: 300,000 Shares Authorized as of December 31, 2021 and September 30, 2021; 98,486 and 98,333 Shares Issued and Outstanding as of December 31, 2021 and September 30, 2021, respectively | ||||||||||||||||||||
| Excess Stock, $0.01 Par Value Per Share: 200,000 Shares Authorized as of September 30, 2020 and 2019; No Shares Issued or Outstanding as of September 30, 2020 and 2019 | ||||||||||||||||||||
| Excess Stock, $0.01 Par Value Per Share: 200,000 Shares Authorized as of December 31, 2021 and September 30, 2021; No Shares Issued or Outstanding as of December 31, 2021 and September 30, 2021 | ||||||||||||||||||||
| Additional Paid-In Capital | ||||||||||||||||||||
| Accumulated Other Comprehensive Loss | ||||||||||||||||||||
| Undistributed Income | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
Loading...
